Description
A major metabolite of lithocholic acid; formed from LCA by CYP3A4; an agonist of TGR5 (EC50 = 0.27 μM), VDR (EC50 = 3 μM), and FXR in cell-based reporter assays; binds to human PXR (IC50 = 15 μM) and activates mouse and human PXRs in cell-based reporter assays at 100 μM; binds to RORγt (Kd = 1.13 μM for the recombinant human ligand-binding domain) and decreases its activity in a cell-based reporter assay at 10 μM; inhibits the differentiation of TH17 cells at 20 μM
Formal name: (5β)-3-oxo-cholan-24-oic acid
Synonyms: 3-Ketolithocholic Acid|3-oxo Lithocholic Acid|3-oxoLCA
Molecular weight: 374.6
CAS: 1553-56-6
Purity: ≥95%
Formulation: A crystalline solid